Harvard study – Exclusive market rights encouraging high drug prices
In a remarkable Harvard Study, the key reasons behind the high drug prices in the United States (US) have been […]
Tags: Aaron Kesselheim, Ameet Sarpatwari, Engelberg Foundation, Food and Drugs Administration, Generic drug, Harvard, Harvard Study, JAMA, Jerry Avorn, John Arnold Foundation, medicaid, Monopoly, Pharma Companies, Prescription drug, research and development, the Journal of the American Medical Association, United States
Shortage of specialists prompting hospitals to adopt eICU technology
A nationwide shortage of critical care specialists has prompted more than three dozen US hospital systems to implement electronic intensive care units, or eICUs, which use telehealth technology to connect remote doctors with critically ill patients.
Cancer drug, when combined, boosts death risk
The cancer drug Avastin, also known as bevacizumab, is linked to a higher risk of death when combined with chemotherapy, said a study in the Journal of the American Medical Association.
NEWS REVIEW – WORLD
[This article was published in the August 2008 issue of the eHEALTH Magazine (https://www.ehealthonline.org)]
World News
